Article By:
InvestorsAlley
Wednesday, May 18, 2022 6:14 AM EDT
GSK is already gearing up for what it hopes will be a bright future. On April 13, GlaxoSmithKline announced a $1.9 billion deal to purchase a U.S. biotech company, Sierra Oncology.
Novavax To Supply 60M Coronavirus Vaccine Doses To UK Under New Deal
I prefer $GSK.. Novavax is too much of a gable for me.